August 31, 2016 3:11 AM ET

Biotechnology

Company Overview of Lysosomal Therapeutics Inc.

Company Overview

Lysosomal Therapeutics Inc. is engaged in small-molecule research and development in the field of neurodegenerative diseases to discover new drugs for patients with severe neurological diseases. The company provides services to target Gaucher-related neurodegeneration, Parkinson’s disease, and other synucleinopathies. Lysosomal Therapeutics Inc. was incorporated in 2011 and is headquartered in Cambridge, Massachusetts.

19 Blackstone Street

Cambridge, MA 02139

United States

Founded in 2011

Phone:

617-913-0166

Key Executives for Lysosomal Therapeutics Inc.

Founder, Chief Executive Officer, President and Director
Founder and Chairman of The Board
Age: 70
Scientific Founder and Chairman of Scientific Advisory Board
Scientific Founder
Founder
Age: 70
Compensation as of Fiscal Year 2016.

Lysosomal Therapeutics Inc. Key Developments

Lysosomal Therapeutics Inc. Presents at 1st Annual Neuroscience BioPartnering & Investment Forum, Feb-23-2016 01:35 PM

Lysosomal Therapeutics Inc. Presents at 1st Annual Neuroscience BioPartnering & Investment Forum, Feb-23-2016 01:35 PM. Venue: The New York Academy of Sciences, 7 World Trade Center, 250 Greenwich St, 40th Floor (D Elevator Bank), New York, NY 10007, United States. Speakers: Cornelis Been, Founder, Chief Executive Officer, President and Director.

Lysosomal Therapeutics Inc. Presents at BIO-Europe 2015, Nov-02-2015

Lysosomal Therapeutics Inc. Presents at BIO-Europe 2015, Nov-02-2015 . Venue: Munich, Germany.

Lysosomal Therapeutics Inc. Presents at 10th Annual Neurotech Investing & Partnering Conference, Apr-08-2015 03:30 PM

Lysosomal Therapeutics Inc. Presents at 10th Annual Neurotech Investing & Partnering Conference, Apr-08-2015 03:30 PM. Venue: Hotel Nikko, 222 Mason Street, San Francisco, California, United States. Speakers: Kees Been, Founder, Chief Executive Officer, President and Director.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3D Bio Holdings LLC United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Bloomberg L.P. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Lysosomal Therapeutics Inc., please visit www.lysosomaltx.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.